Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2017

Jul 31, 2017

30597_dirs_2017-07-31_e834e23d-32ba-4e14-9b97-bb2618605b66.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2017-07-27

Reporting Person: WYZGA MICHAEL S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-07-27 Common Stock A 791 $0.00 Acquired 18376 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-07-27 Deferred Stock Units $0.00 A 5273 Acquired Common Stock (5273) Direct

Footnotes

F1: These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy.

F2: Represents deferred stock unit award issued pursuant to the Company's non-employee director compensation policy. Each deferred stock unit represents a contingent right to receive one share of common stock.

F3: These deferred stock units vest in full on the first anniversary of the grant date or, if earlier, the date of the next annual meeting of the Company's stockholders. Deferred stock units that become earned and vested are payable upon separation of service.